Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis

Hossein Borghaei, Tudor–Eliade Ciuleanu, J.-S. Lee, Adam Płużański, R. Bernabe Caro, Martin Gutierrez, Yuichiro Ohe, Makoto Nishio, Jonathan W. Goldman, Neal Ready, David R. Spigel, Sundhar Ramalingam, Luis Paz‐Ares, Justin F. Gainor, S. Ahmed, Martin Reck, Michele Maio, Kenneth J. O’Byrne, Arteid Memaj, Faith E. Nathan, Phuong Tran, Matthew D. Hellmann, Julie R. Brahmer